Company Management, Scientific and Advisory Boards

Hematology publications

Chajari, M., Lacroix, J., Peny, A.-M., Chesnay, E., Batalla, A., Henry-Amar, M., … Bardet, S. (2002). Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography? European Journal of Nuclear Medicine and Molecular Imaging, 29(3), 380–387. https://doi.org/10.1007/s00259-001-0704-2
Rolland, D., Ribrag, V., Haioun, C., Ghesquieres, H., Jardin, F., Bouabdallah, R., … Thieblemont, C. (2010). Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe d’Etude des Lymphomes de l’Adulte trial. Cancer Chemotherapy and Pharmacology, 65(4), 781–790. https://doi.org/10.1007/s00280-009-1185-4
Moulin-Romsee, G., Hindié, E., Cuenca, X., Brice, P., Decaudin, D., Bénamor, M., … Moretti, J.-L. (2010). 18F-FDG PET/CT bone/bone marrow findings in Hodgkin’s lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. European Journal of Nuclear Medicine and Molecular Imaging, 37(6), 1095–1105. https://doi.org/10.1007/s00259-009-1377-5
Itti, E., Juweid, M. E., Haioun, C., Yeddes, I., Hamza-Maaloul, F., El Bez, I., … Meignan, M. (2010). Improvement of Early 18F-FDG PET Interpretation in Diffuse Large B-Cell Lymphoma: Importance of the Reference Background. Journal of Nuclear Medicine, 51(12), 1857–1862. https://doi.org/10.2967/jnumed.110.080556
de Bazelaire, C., & de Kerviler, E. (2011). From multislice CT to whole-body biomarker imaging in lymphoma patients. European Radiology, 21(3), 555–558. https://doi.org/10.1007/s00330-010-2035-9
Schnell, D., Mayaux, J., de Bazelaire, C., Legoff, J., Feuillet, S., Scieux, C., … Azoulay, É. (2010). Risk factors for pneumonia in immunocompromised patients with influenza. Respiratory Medicine, 104(7), 1050–1056. https://doi.org/10.1016/j.rmed.2010.01.021
Safar, V., Dupuis, J., Itti, E., Jardin, F., Fruchart, C., Bardet, S., … Haioun, C. (2012). Interim [ 18 F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab. Journal of Clinical Oncology, 30(2), 184–190. https://doi.org/10.1200/JCO.2011.38.2648
Leseur, J., Devillers, A., Williaume, D., Le Prisé, E., Fougerou, C., Bouriel, C., … Garin, E. (2011). Tomographie par émission de positons au (18F)-fluorodésoxyglucose dans les cancers du col utérin : évaluation ganglionnaire et valeur pronostique/prédictive des données de la tumeur primitive. Cancer/Radiothérapie, 15(8), 699–708. https://doi.org/10.1016/j.canrad.2011.05.013
Casasnovas, R.-O., Meignan, M., Berriolo-Riedinger, A., Bardet, S., Julian, A., Thieblemont, C., … Morschhauser, F. (2011). SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma. Blood, 118(1), 37–43. https://doi.org/10.1182/blood-2010-12-327767
Sibon, D., Ertault, M., Al Nawakil, C., de Bazelaire, C., Franchi, P., Brière, J., … Brice, P. (2011). Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients: IVOx Salvage Regimen for Hodgkin Lymphoma. British Journal of Haematology, 153(2), 191–198. https://doi.org/10.1111/j.1365-2141.2011.08594.x
Romero, M., Brière, J., de Bazelaire, C., Lebœuf, C., Wang, L., Ratajczak, P., … Janin, A. (2011). Aflibercept-mediated early angiogenic changes in aggressive B-cell lymphoma. Cancer Chemotherapy and Pharmacology, 68(5), 1135–1143. https://doi.org/10.1007/s00280-011-1589-9
de Kerviler, E., Benet, C., Brière, J., & de Bazelaire, C. (2012). Image-guided needle biopsy for diagnosis and molecular biology in lymphomas. Best Practice & Research Clinical Haematology, 25(1), 29–39. https://doi.org/10.1016/j.beha.2012.01.006
Bergeron, A., Porcher, R., Sulahian, A., de Bazelaire, C., Chagnon, K., Raffoux, E., … Ribaud, P. (2012). The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood, 119(8), 1831–1837. https://doi.org/10.1182/blood-2011-04-351601
Biggi, A., Gallamini, A., Chauvie, S., Hutchings, M., Kostakoglu, L., Gregianin, M., … Barrington, S. F. (2013). International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers. Journal of Nuclear Medicine, 54(5), 683–690. https://doi.org/10.2967/jnumed.112.110890
Itti, E., Meignan, M., Berriolo-Riedinger, A., Biggi, A., Cashen, A. F., Véra, P., … Haioun, C. (2013). An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax. European Journal of Nuclear Medicine and Molecular Imaging, 40(9), 1312–1320. https://doi.org/10.1007/s00259-013-2435-6
Gay, J., Lemiale, V., Meignin, V., Bron, C., De Bazelaire, C., Schnell, D., … Azoulay, E. (2013). Diagnostic contribution from pulmonary biopsies in hematology patients with acute respiratory failure from undetermined etiology. Minerva Anestesiologica, 79(8), 853–860.
de Bazelaire, C., Coffin, A., Cohen-Zarade, S., de Margerie-Mellon, C., Scemama, A., Sabatier, F., … de Kerviler, E. (2013). CT-guided biopsies in lung infections in patients with haematological malignancies. Diagnostic and Interventional Imaging, 94(2), 202–215. https://doi.org/10.1016/j.diii.2012.12.008
Bailly, C., Eugène, T., Couec, M.-L., Strullu, M., Frampas, E., Campion, L., … Bodet-Milin, C. (2014). Prognostic Value and Clinical Impact of 18FDG-PET in the Management of Children with Burkitt Lymphoma after Induction Chemotherapy. Frontiers in Medicine, 1. https://doi.org/10.3389/fmed.2014.00054
D’Anastasi, M., Notohamiprodjo, M., Schmidt, G. P., Dürr, H.-R., Reiser, M. F., & Baur-Melnyk, A. (2014). Tumor Load in Patients With Multiple Myeloma: β 2 -Microglobulin Levels Versus Whole-Body MRI. American Journal of Roentgenology, 203(4), 854–862. https://doi.org/10.2214/AJR.13.10724
Monjanel, H., Deville, L., Ram-Wolff, C., Venon, M.-D., Franchi, P., Benet, C., … Brice, P. (2014). Brentuximab vedotin in heavily treated Hodgkin and anaplastic large-cell lymphoma, a single centre study on 45 patients. British Journal of Haematology, 166(2), 306–308. https://doi.org/10.1111/bjh.12849
Fleury, I., Amorim, S., Mounier, N., Coiffier, B., Dupuis, J., Tilly, H., … Thieblemont, C. (2015). Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study. Leukemia & Lymphoma, 56(7), 2025–2031. https://doi.org/10.3109/10428194.2014.977884
Illidge, T. M., Mayes, S., Pettengell, R., Bates, A. T., Bayne, M., Radford, J. A., … Morschhauser, F. (2014). Fractionated 90 Y-Ibritumomab Tiuxetan Radioimmunotherapy As an Initial Therapy of Follicular Lymphoma: An International Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria. Journal of Clinical Oncology, 32(3), 212–218. https://doi.org/10.1200/JCO.2013.50.3110
Sasanelli, M., Meignan, M., Haioun, C., Berriolo-Riedinger, A., Casasnovas, R.-O., Biggi, A., … Itti, E. (2014). Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma. European Journal of Nuclear Medicine and Molecular Imaging, 41(11), 2017–2022. https://doi.org/10.1007/s00259-014-2822-7
Schlemmer, F., Chevret, S., Lorillon, G., De Bazelaire, C., Peffault de Latour, R., Meignin, V., … Bergeron, A. (2014). Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation. Respiratory Medicine, 108(10), 1525–1533. https://doi.org/10.1016/j.rmed.2014.09.006
Varma, G., Duhamel, G., de Bazelaire, C., & Alsop, D. C. (2015). Magnetization transfer from inhomogeneously broadened lines: A potential marker for myelin: Magnetization Transfer from Inhomogeneously Broadened Lines. Magnetic Resonance in Medicine, 73(2), 614–622. https://doi.org/10.1002/mrm.25174
Bernard, S., Goldwirt, L., Amorim, S., Brice, P., Brière, J., de Kerviler, E., … Thieblemont, C. (2015). Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse. Blood, 126(14), 1695–1698. https://doi.org/10.1182/blood-2015-05-647834
Battistella, M., Sallé de Chou, C., de Bazelaire, C., Cayuela, J. M., de Kerviler, E., Bagot, M., & Janin, A. (2016). Lymph node image-guided core-needle biopsy for cutaneous T-cell lymphoma staging. British Journal of Dermatology, 175(6), 1397–1400. https://doi.org/10.1111/bjd.14850
Bodet-Milin, C., Kraeber-Bodéré, F., Eugène, T., Guérard, F., Gaschet, J., Bailly, C., … Chevallier, P. (2016). Radioimmunotherapy for Treatment of Acute Leukemia. Seminars in Nuclear Medicine, 46(2), 135–146. https://doi.org/10.1053/j.semnuclmed.2015.10.007
Moreau, P., Attal, M., Caillot, D., Macro, M., Karlin, L., Garderet, L., … Kraeber-Bodere, F. (2017). Prospective Evaluation of Magnetic Resonance Imaging and [ 18 F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study. Journal of Clinical Oncology, 35(25), 2911–2918. https://doi.org/10.1200/JCO.2017.72.2975
Bailly, C., Leforestier, R., Jamet, B., Carlier, T., Bourgeois, M., Guérard, F., … Bodet-Milin, C. (2017). PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients. International Journal of Molecular Sciences, 18(2), 445. https://doi.org/10.3390/ijms18020445
Zwarthoed, C., El-Galaly, T. C., Canepari, M., Ouvrier, M. J., Viotti, J., Ettaiche, M., … Gallamini, A. (2017). Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study. Journal of Nuclear Medicine, 58(8), 1249–1254. https://doi.org/10.2967/jnumed.116.184218
Kraeber-Bodere, F., Pallardy, A., Maisonneuve, H., Campion, L., Moreau, A., Soubeyran, I., … Soubeyran, P. (2017). Consolidation anti-CD22 fractionated radioimmunotherapy with 90 Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial. The Lancet Haematology, 4(1), e35–e45. https://doi.org/10.1016/S2352-3026(16)30168-5
Delfau-Larue, M.-H., van der Gucht, A., Dupuis, J., Jais, J.-P., Nel, I., Beldi-Ferchiou, A., … Itti, E. (2018). Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma. Blood Advances, 2(7), 807–816. https://doi.org/10.1182/bloodadvances.2017015164
Chantepie, S., Hovhannisyan, N., Guillouet, S., Pelage, J.-P., Ibazizene, M., Bodet-Milin, C., … Barré, L. (2018). 18 F-Fludarabine PET for Lymphoma Imaging: First-in-Humans Study on DLBCL and CLL Patients. Journal of Nuclear Medicine, 59(9), 1380–1385. https://doi.org/10.2967/jnumed.117.206920
Burggraaff, C. N., Cornelisse, A. C., Hoekstra, O. S., Lugtenburg, P. J., De Keizer, B., Arens, A. I. J., … Zijlstra, J. M. (2018). Interobserver Agreement of Interim and End-of-Treatment 18 F-FDG PET/CT in Diffuse Large B-Cell Lymphoma: Impact on Clinical Practice and Trials. Journal of Nuclear Medicine, 59(12), 1831–1836. https://doi.org/10.2967/jnumed.118.210807
Bailly, C., Gouard, S., Lacombe, M., Saëc, P. R.-L., Chalopin, B., Bourgeois, M., … Bodet-Milin, C. (2018). Comparison of Immuno-PET of CD138 and PET imaging with 64CuCl2 and 18F-FDG in a preclinical syngeneic model of multiple myeloma. Oncotarget, 9(10). https://doi.org/10.18632/oncotarget.23886
Bailly, C., Carlier, T., Jamet, B., Eugene, T., Touzeau, C., Attal, M., … Bodet-Milin, C. (2018). Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study. Clinical Cancer Research, 24(21), 5219–5224. https://doi.org/10.1158/1078-0432.CCR-18-0741
Bouard, L., Bodet-Milin, C., Bailly, C., Guillaume, T., Peterlin, P., Garnier, A., … Chevallier, P. (2019). Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients. Biology of Blood and Marrow Transplantation, 25(5), 906–911. https://doi.org/10.1016/j.bbmt.2018.11.019
Chiche, J., Reverso-Meinietti, J., Mouchotte, A., Rubio-Patiño, C., Mhaidly, R., Villa, E., … Ricci, J.-E. (2019). GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors. Cell Metabolism, 29(6), 1243-1257.e10. https://doi.org/10.1016/j.cmet.2019.02.002